Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Kaleido Biosciences (KLDO)

Kaleido Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KLDO
DateTimeSourceHeadlineSymbolCompany
06/05/202213:16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:KLDOKaleido Biosciences Inc
02/05/202211:20Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KLDOKaleido Biosciences Inc
27/04/202210:03TipRanksAnalysts Offer Insights on Healthcare Companies: and Kaleido Biosciences (KLDO)NASDAQ:KLDOKaleido Biosciences Inc
25/04/202221:43Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KLDOKaleido Biosciences Inc
25/04/202221:41Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KLDOKaleido Biosciences Inc
18/04/202214:25Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:KLDOKaleido Biosciences Inc
08/04/202214:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
04/04/202212:45TipRanksKaleido Biosciences (KLDO) was Downgraded to a Hold Rating at Chardan CapitalNASDAQ:KLDOKaleido Biosciences Inc
16/03/202212:30GlobeNewswire Inc.Radius Health Announces Leadership AppointmentsNASDAQ:KLDOKaleido Biosciences Inc
09/03/202221:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
02/03/202221:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
02/03/202221:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
28/02/202214:00PR Newswire (US)Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory AffairsNASDAQ:KLDOKaleido Biosciences Inc
15/02/202215:05PR Newswire (US)INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANTNASDAQ:KLDOKaleido Biosciences Inc
09/02/202214:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KLDOKaleido Biosciences Inc
28/01/202221:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
21/01/202216:04GlobeNewswire Inc.Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis CongressNASDAQ:KLDOKaleido Biosciences Inc
18/01/202222:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
18/01/202222:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
18/01/202222:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
18/01/202222:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
16/12/202122:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
16/12/202122:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:KLDOKaleido Biosciences Inc
06/12/202112:30GlobeNewswire Inc.Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic ConditionsNASDAQ:KLDOKaleido Biosciences Inc
15/11/202112:30GlobeNewswire Inc.Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ConferenceNASDAQ:KLDOKaleido Biosciences Inc
10/11/202112:30GlobeNewswire Inc.Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical OfficerNASDAQ:KLDOKaleido Biosciences Inc
01/11/202111:30GlobeNewswire Inc.Kaleido Biosciences Reports Third Quarter 2021 Financial ResultsNASDAQ:KLDOKaleido Biosciences Inc
13/10/202115:11PR Newswire (US)Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate ChangeNASDAQ:KLDOKaleido Biosciences Inc
12/10/202112:30GlobeNewswire Inc.Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics SummitNASDAQ:KLDOKaleido Biosciences Inc
05/10/202112:00GlobeNewswire Inc.Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement of KB295 to a Phase 2 Clinical Study in Mild-to-Moderate Ulcerative ColitisNASDAQ:KLDOKaleido Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:KLDO

Your Recent History

Delayed Upgrade Clock